QuantumSi is trading at $0.89, up 12.48%, after interim Proteus results showed stronger performance than Platinum Pro.
- Across reported sequencing measures, a control-peptide study showed 30 times more alignments with Proteus.
- QuantumSi presented the interim results at the World HUPO Congress on September 29, 2026.
- Broader indices were nearly flat in the supplied market context; no volume figure was available.